(1 - 22 von 26
)
Biogen (BIIB) Q Earnings Call TranscriptThe Globe and Mail
www.theglobeandmail.com
— Mike Hencke, head of investor relations. Mr. Hencke, you may begin your conference. Michael Hencke -- Head of Investor Relations. Thank you.
Biogen and Bio-Thera Announce Positive Results From ...kauppalehti.fi
www.kauppalehti.fi
— Natacha Gassenbach, Mike Hencke. Biogen Inc. Biogen Inc. Tel: (781) , Tel: (781) BIO-THERA SOLUTIONS MEDIA CONTACT: — MEDIA CONTACT: David Caouette + , INVESTOR CONTACT: Mike Hencke +
Biogen's FAMPYRA Granted Standard Marketing Authorization in European...
www.finanznachrichten.de
MEDIA CONTACT: Lindsey Smith, + or. INVESTOR CONTACT: Mike Hencke, +
BIIB - Biogen Inc.AlphaStreet
news.alphastreet.com
Biogen Inc. (NASDAQ: BIIB) Q earnings call dated Oct. 25, Corporate Participants: Mike Hencke -- Head, Investor Relations Michel Vounatsos ...
Biogen: Eisai Submits Marketing Authorization Application ...Finanznachrichten
www.finanznachrichten.de
— Biogen Inc. Mike Hencke + Source: Eisai Copyright JCN Newswire .
Global Drug Intelligence DatabasePatSnap
synapse.patsnap.com
Biogen Mike Hencke + For more details,please visit the original website. The content of the article does not represent any ...
Festkonzert Nun heben Töne an zu klingen und zu ...Berlin.de
www.berlin.de
— Thomas Terzibaschian, Yorick Fuhrmann, Ulrike Seidel, Sabine Kohlhofer, Mike Hencke,. Bettina Fabiunke, Nadja Cocozza, Tilo Schmalenberg, ...
Neue Daten zu AducanumabNeurologienetz
www.neurologienetz.de
— Mike Hencke + IR(at)biogen.com. Ansprechpartner bei Eisai für Medienvertreter: Eisai Co., Ltd. Public Relations Department
Biogen and Abbvie Receive Positive Opinion From The CHMP on ZINBRYTA™...
news.abbvie.com
Share to Facebook Share to Twitter Share to Linkedin Email Sign Up for Alerts Print. - Positive Biogen Mike Hencke Ph: +
PressemitteilungenBiogen GmbH
www.biogen.de
— Mike Hencke Biogen Inc. Tel: + Ansprechpartner bei Biogen für Medienvertreter in Deutschland:
Biogen et AbbVie obtiennent de Santé Canada l'homologation de...
www.newswire.ca
... AbbVie : Jillian Griffin, Tél. : + , ; CONTACT POUR LES INVESTISSEURS : Biogen : Mike Hencke, ...
eisai and biogen inc. announce us fda grants breakthroughEisai
www.eisai.com
— Mike Hencke. + [Notes to editors]. About Lecanemab (BAN2401). Lecanemab is an investigational humanized ...
Biogen Announces Exercise of Option to Acquire the ...株式会社ティムス
www.tms-japan.co.jp
— Mike Hencke. + TMS MEDIA CONTACT: .jp. TMS INVESTOR CONTACT: .jp.
Biogen Sweden ABMynewsdesk
www.mynewsdesk.com
— MEDIA CONTACT: Biogen. Jack Cox. + INVESTOR CONTACT: Biogen. Mike Hencke. +
New Data Presented At ECTRIMS Reinforce Efficacy of ZINBRYTA™...
news.abbvie.com
AbbVie. Jillian Griffin Ph: + , INVESTOR CONTACT: Biogen Mike Hencke
Eisai Submits Supplemental BioGuruFocus
www.gurufocus.com
— Eisai Co., Ltd. Investor Relations Department. TEL: +81 (0) Biogen Inc. Mike Hencke. +
Eisai: Additional Detailed Analyses from Phase 2 Study ...MarketScreener
www.marketscreener.com
— Mike Hencke. + Biogen Safe Harbor. This news release contains forward-looking statements, ...
Stockwatch
www.stockwatch.com
No Hype - just the Facts. Your complete source of news and realtime quotes from the TSX, TSX-V, CSE, Montreal, Nasdaq, NYSE, Amex and OTC Markets.
New Data Presented at the Annual European Congress of Rheumatology...
www.emjreviews.com
Data confirm safety and efficacy of switching from Enbrel® and Remicade® to BENEPALI® and FLIXABI® respectively
New Data Presented At ECTRIMS Reinforce Efficacy of ...AbbVie
news.abbvie.com
— AbbVie. Jillian Griffin Ph: + , INVESTOR CONTACT: Biogen Mike Hencke Ph: +
News Releasessamsungbioepis.com
m.samsungbioepis.com
— For Investors: Mike Hencke, + , . For Media: Allison Parks, + , .
Update on Regulatory Submission for Aducanumab in the ...TeleTrader.com
www.teletrader.com
— Mike Hencke + Eisai Co., Ltd. Public Relations Department TEL : +81 (0) , Eisai Co., Ltd.
sortiert nach Relevanz / Datum